Abstract:An increase in SP‐A and SP‐D amount has been seen in the moderate COVID‐19, but in the severe stages of the disease due to the destruction of type 2 alveolar cells, which are the main producers of surfactants, these amounts will be reduced. Background Severe cases of COVID‐19 often lead to the development of acute respiratory syndrome, a critical condition believed to be caused by the harmful effects of SARS‐CoV‐2 on type II alveolar cells. These cells play a crucial role in producing pulmonary surfactants, which are essential for proper lung function. Specifically focusing on surfactant proteins, including Surfactant protein A (SP‐A), Surfactant protein B, Surfactant protein C, and Surfactant protein D (SP‐D), changes in the levels of pulmonary surfactants may be a significant factor in the pathological changes seen in COVID‐19 infection. Objective This study aims to gain insights into surfactants, particularly their impacts and changes during COVID‐19 infection, through a comprehensive review of current literature. The study focuses on the function of surfactants as prognostic markers, diagnostic factors, and essential components in the management and treatment of COVID‐19. Finding In general, pulmonary surfactants serve to reduce the surface tension at the gas–liquid interface, thereby significantly contributing to the regulation of respiratory mechanics. Additionally, these surfactants play a crucial role in the innate immune system within the pulmonary microenvironment. Within the spectrum of COVID‐19 infections, a compelling association is observed, characterized by elevated levels of SP‐D and SP‐A across a range of manifestations from mild to severe pneumonia. The sudden decline in respiratory function observed in COVID‐19 patients may be attributed to the decreased synthesis of surfactants by type II alveolar cells. Conclusion Collectin proteins such as SP‐A and SP‐D show promise as biomarkers, offering potential avenues for predicting and monitoring pulmonary alveolar injury in the context of COVID‐19. This clarification enhances our understanding of the molecular complexities contributing to respiratory complications in severe COVID‐19 cases, providing a foundation for targeted therapeutic approaches using surfactants and refined clinical management strategies.

Pulmonary Immunohistochemistry and Serum Levels of a Surfactant-Associated Protein A in Fatal Drowning

Pulmonary Surfactant-Associated Protein A As a Marker of Respiratory Distress in Forensic Pathology: Assessment of the Immunohistochemical and Biochemical Findings

Immunohistochemical investigation of pulmonary surfactant-associated protein A in fatal poisoning

Postmortem Serum Levels of Pulmonary Surfactant-Associated Proteins A and D with Regard to the Cause of Death in Medicolegal Autopsy

Immunohistochemistry of Pulmonary Surfactant Apoprotein A in Forensic Autopsy: Reassessment in Relation to the Causes of Death

Immunohistochemical Investigation of Pulmonary Surfactant-Associated Protein A in Fire Victims

Pulmonary Surfactant-Associated Protein A Levels in Cadaveric Sera with Reference to the Cause of Death

Immunohistochemistry of Pulmonary Surfactant-Associated Protein A in Acute Respiratory Distress Syndrome.

Analysis of postmortem biochemical findings with regard to the lung weight in drowning

Postmortem Lung Weight in Drownings: a Comparison with Acute Asphyxiation and Cardiac Death

Role of surfactant-associated protein A in lung injury due to drowning

Phospholipid Changes of Pulmonary Surfactant in Rats with Pulmonary Edema after Seawater Drowning

Lung–heart Weight Ratio As a Possible Index of Cardiopulmonary Pathophysiology in Drowning

Possible Postmortem Serum Markers for Differentiation Between Fresh-, Saltwater Drowning and Acute Cardiac Death: a Preliminary Investigation.

Determination of Serum Pulmonary Surfactant Protein A and Its Significance in Patients with Acute Lung Injury

Ultrasonographic Densitometry of the Lungs at Autopsy: a Preliminary Investigation for Possible Application in Forensic Pathology

Application of Quantitative Analysis of Diatoms in Lung Tissue for the Diagnosis of Drowning of Experimental Animals.

Seawater-drowning-induced Acute Lung Injury: from Molecular Mechanisms to Potential Treatments

Unraveling the enigma: The emerging significance of pulmonary surfactant proteins in predicting, diagnosing, and managing COVID‐19

Study Progress on Pathogenesis of Pulmonary Edema Induced by Seawater Drowning

A Rare Type of Drowning with a Latent Period Following Surviving an Episode of Immersion